CD28 and neoplasm: Patients stratified into high and low groups based on the proportion of tumor-infiltrating CD28+PD1−/CD8+ T cells using a cut-off value of 1.55% demonstrated that the high-proportion group had prolonged PFS (p = 0.018) (Figure 3F).